Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease

References

• Adams LA , Lymp JF , St Sauver J , et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology . 2005;129(1):113–121. doi:10.1053/j.gastro.2005.04.014 16012941
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Koenig AB , Abdelatif D , et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64(1):73–84. doi:10.1002/hep.28431 26707365
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Golabi P , de Avila L , et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol . 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021 31279902
   PubMed Web of Science ®Google Scholar
• Mantovani A , Petracca G , Beatrice G , et al. Nonalcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501022 adult individuals. Gut . 2020;gutjnl-2020-322572. doi:10.1136/gutjnl-2020-322572.
   Web of Science ®Google Scholar
• Khanal UP , Paudel B , Gurung G , et al. Correlational study of nonalcoholic fatty liver disease diagnosed by ultrasonography with lipid profile and body mass index in adult Nepalese population. J Med Ultrasound . 2019;27(1):19–25. doi:10.4103/JMU.JMU_53_18 31031531
   PubMed Web of Science ®Google Scholar
• Foucher J , Chanteloup E , Vergniol J , et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut . 2006;55(3):403–408. doi:10.1136/gut.2005.069153 16020491
   PubMed Web of Science ®Google Scholar
• Dyson JK , Anstee QM , McPherson S . Nonalcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol . 2014;5(3):211–218. doi:10.1136/flgastro-2013-100403 25018867
   PubMedGoogle Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet . 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3.14726171
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation . 2002;106(25):3143–3421. doi:10.1161/circ.106.25.3143.12485966
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA , Gurusamy KS , Ntaoula S , et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol . 2011;54(4):650–659. doi:10.1016/j.jhep.2010.07.033 21146892
   PubMed Web of Science ®Google Scholar
• Hashemi SA , Alavian SM , Gholami-Fesharaki M . Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Caspian J Intern Med . 2016;7(4):242–252.27999641
   PubMedGoogle Scholar
• Newsome PN , Sasso M , Deeks JJ , et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with nonalcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol . 2020;5(4):362–373. doi:10.1016/S2468-1253(19)303838 32027858
   PubMed Web of Science ®Google Scholar
• Eddowes PJ , Sasso M , Allison M , et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology . 2019;156(6):1717–1730. doi:10.1053/j.gastro.2019.01.042 30689971
   PubMed Web of Science ®Google Scholar
• Kumar R , Rastogi A , Sharma MK , et al. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci . 2013;58(1):265–274. doi:10.1007/s10620-012-2306-1 22790906
   PubMed Web of Science ®Google Scholar
• Younossi Z , Anstee QM , Marietti M , et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol . 2018;15(1):11–20. doi:10.1038/nrgastro.2017.109 28930295
   PubMed Web of Science ®Google Scholar
• Kalra S , Vithalani M , Gulati G , et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India . 2013;61(7):448–453.24772746
   PubMedGoogle Scholar
• Alam S , Fahim SM , Chowdhury MAB , et al. Prevalence and risk factors of nonalcoholic fatty liver disease in Bangladesh. JGH Open . 2018;2(2):39–46. doi:10.1002/jgh3.12044 30483562
   PubMed Web of Science ®Google Scholar
• Li Y , Wang J , Tang Y , et al. Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: evidence from the Dongfeng-Tongji cohort study. PLoS One . 2017;12(3):e0174291. doi:10.1371/journal.pone.0174291 28350839
   PubMed Web of Science ®Google Scholar
• Dai W , Ye L , Liu A , et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine . 2017;96(39):e8179. doi:10.1097/MD.0000000000008179 28953675
   PubMed Web of Science ®Google Scholar
• Lazo M , Clark JM . The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis . 2008;28(4):339–350. doi:10.1055/s-0028-1091978 18956290
   PubMed Web of Science ®Google Scholar
• Tada T , Toyoda H , Sone Y , et al. Type 2 diabetes mellitus: a risk factor for progression of liver fibrosis in middle-aged patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol . 2019;34(11):2011–2018. doi:10.1111/jgh.14734 31115065
   PubMed Web of Science ®Google Scholar
• Chen K , Sng WK , Quah JH , et al. Clinical spectrum of nonalcoholic fatty liver disease in patients with diabetes mellitus. PLoS One . 2020;15(8):e0236977. doi:10.1371/journal.pone.0236977 32822391
   PubMed Web of Science ®Google Scholar
• Lai -L-L , Wan Yusoff WNI , Vethakkan SR , et al. Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. J Gastroenterol Hepatol . 2019;34(8):1396–1403. doi:10.1111/jgh.14577 30551263
   PubMed Web of Science ®Google Scholar
• Fallatah HI , Akbar HO , Fallatah AM . Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease. Hepat Mon . 2016;16(7):e38346. doi:10.5812/hepatmon.38346 27642348
   PubMed Web of Science ®Google Scholar
• Tewari A , Tewari V , Tewari J . Screening for nonalcoholic liver disease in type 2 diabetic patients and its association with age, BMI and duration of diabetes mellitus- A cross-sectional study. J Clin Diag Res . 2021;15(4):OC27–OC30. doi:10.7860/JCDR/2021/47105.14788
   Web of Science ®Google Scholar
• Lomonaco R , Godinez Leiva E , Bril F , et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening. Diabetes Care . 2021;44(2):399–406. doi:10.2337/dc20-1997 33355256
   PubMed Web of Science ®Google Scholar
• Ciardullo S , Monti T , Perseghin G . High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes. Diabetes Care . 2021;44(2):519–525. doi:10.2337/dc20-1778 33303638
   PubMed Web of Science ®Google Scholar
• Tuong TTK , Tran DK , Phu PQT , et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes: evaluation of hepatic fibrosis and steatosis using Fibroscan. Diagnostics . 2020;10(3):159. doi:10.3390/diagnostics10030159
   Web of Science ®Google Scholar
• Mofrad P , Contos MJ , Haque M , et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology . 2003;37(6):1286–1292. doi:10.1053/jhep.2003.50229 12774006
   PubMed Web of Science ®Google Scholar
• Verma S , Jensen D , Hart J , et al. Predictive value of ALT levels for nonalcoholic steatohepatitis (NASH) and advanced fibrosis in nonalcoholic fatty liver disease (NAFLD). Liver Int . 2013;33(9):1398–1405. doi:10.1111/liv.12226 23763360
   PubMed Web of Science ®Google Scholar
• Hernaez R , Lazo M , Bonekamp S , et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology . 2011;54(3):1082–1090. doi:10.1002/hep.24452 21618575
   PubMed Web of Science ®Google Scholar
• Koehler EM , Plompen EP , Schouten JN , et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study. Hepatology . 2016;63(1):138–147. doi:10.1002/hep.27981 26171685
   PubMed Web of Science ®Google Scholar
• Kamali L , Adibi A , Ebrahimian S , et al. Diagnostic performance of ultrasonography in detecting fatty liver disease in comparison with FibroScan in people suspected of fatty liver. Adv Biomed Res . 2019;8:69. doi:10.4103/abr.abr_114_19 31897407
   PubMedGoogle Scholar